NCT02237365 - A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

October 17, 2014

Primary Completion Date

June 24, 2016

Study Completion Date

December 22, 2016

Conditions

Tuberculous Meningitis

Interventions

DRUG

81mg aspirin

1 tablet of 81mg aspirin and 2 tablets of placebo (visually matched to 500mg aspirin) daily for 60 days

DRUG

1000mg aspirin

1 tablet of 81mg placebo (visually matched to 81mg aspirin) and 2 tablets of 500mg aspirin daily for 60 days

DRUG

Placebo

1 tablet of 81mg placebo (visually matched to 81mg aspirin) and 2 tablets of 500mg placebo (visually matched to 500mg aspirin) daily for 60 days

Trial Locations (1)

Hospital for Tropical Diseases, Ho Chi Minh City

All Listed Sponsors

collaborator

Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

OTHER

lead

Oxford University Clinical Research Unit, Vietnam

OTHER